# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-19-025202
Filing Date
2019-12-03
Accepted
2019-12-03 16:03:48
Documents
32
Period of Report
2019-11-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | f8k112719_relmada.htm | 8-K | 41772
2 | AMENDED AND RESTATED UNIT PURCHASE AGREEMENT DATED NOVEMBER 27, 2019, BETWEEN RE | f8k112719ex10-1_relmada.htm | EX-10.1 | 233278
3 | AMENDMENT NO.1 TO LICENSE AGREEMENT DATED DECEMBER 2, 2019, TO THE LICENSE AGREE | f8k112719ex10-2_relmada.htm | EX-10.2 | 21636
4 | UPDATED BUSINESS, DIRECTORS AND EXECUTIVE OFFICERS AND CERTAIN RELATIONSHIPS AND | f8k112719ex99-1_relmada.htm | EX-99.1 | 266850
5 | UPDATED RISK FACTORS | f8k112719ex99-2_relmada.htm | EX-99.2 | 327143
6 | CORPORATE PRESENTATION, DATED DECEMBER 2019 | f8k112719ex99-3_relmada.htm | EX-99.3 | 31839
7 | GRAPHIC | ex99-3_001.jpg | GRAPHIC | 373183
8 | GRAPHIC | ex99-3_002.jpg | GRAPHIC | 171561
9 | GRAPHIC | ex99-3_003.jpg | GRAPHIC | 187249
10 | GRAPHIC | ex99-3_004.jpg | GRAPHIC | 266147
11 | GRAPHIC | ex99-3_005.jpg | GRAPHIC | 193297
12 | GRAPHIC | ex99-3_006.jpg | GRAPHIC | 244957
13 | GRAPHIC | ex99-3_007.jpg | GRAPHIC | 93297
14 | GRAPHIC | ex99-3_008.jpg | GRAPHIC | 186009
15 | GRAPHIC | ex99-3_009.jpg | GRAPHIC | 179323
16 | GRAPHIC | ex99-3_010.jpg | GRAPHIC | 223069
17 | GRAPHIC | ex99-3_011.jpg | GRAPHIC | 256085
18 | GRAPHIC | ex99-3_012.jpg | GRAPHIC | 177854
19 | GRAPHIC | ex99-3_013.jpg | GRAPHIC | 249143
20 | GRAPHIC | ex99-3_014.jpg | GRAPHIC | 248853
21 | GRAPHIC | ex99-3_015.jpg | GRAPHIC | 182751
22 | GRAPHIC | ex99-3_016.jpg | GRAPHIC | 162030
23 | GRAPHIC | ex99-3_017.jpg | GRAPHIC | 239244
24 | GRAPHIC | ex99-3_018.jpg | GRAPHIC | 131228
25 | GRAPHIC | ex99-3_019.jpg | GRAPHIC | 142471
26 | GRAPHIC | ex99-3_020.jpg | GRAPHIC | 113279
27 | GRAPHIC | ex99-3_021.jpg | GRAPHIC | 161686
28 | GRAPHIC | ex99-3_022.jpg | GRAPHIC | 126596
29 | GRAPHIC | ex99-3_023.jpg | GRAPHIC | 47404
30 | GRAPHIC | ex99-3_024.jpg | GRAPHIC | 187358
31 | GRAPHIC | ex99-3_025.jpg | GRAPHIC | 163681
32 | GRAPHIC | ex99-3_026.jpg | GRAPHIC | 373183
| Complete submission text file | 0001213900-19-025202.txt |  | 7924546

Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39082 | Film No.: 191265844
SIC: 2834 Pharmaceutical Preparations